Multiple rising doses of oral BI 1358894 in healthy male volunteers: a phase I study investigating safety, tolerability and pharmacokinetics

被引：3
|
作者：
Goettel, M. [1 ]
Fuertig, R. [2 ]
Wiebe, S. [2 ]
Herich, L. [3 ]
Sharma, V. [4 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Global Clin Operat, Ingelheim, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, Biberach, Germany
[3] Staburo GmbH, Munich, Germany
[4] Boehringer Ingelheim Pharma GmbH & Co KG, TA CNS Retinopathies Emerging Areas Med, Ingelheim, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 40卷
关键词：
D O I：
10.1016/j.euroneuro.2020.09.330
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.447
引用
收藏
页码：S254 / S255
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics, tolerability, and safety of pirfenidone (PFD), an antifibrotic agent, following single and multiple oral doses in healthy volunteers
    Shi, Shaojun
    Wu, Jianhong
    Chen, Huating
    Chen, Hui
    Wu, Jun
    Zeng, Fandian
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 197 - 197
  • [22] Safety, tolerability, and pharmacokinetics of single and multiple doses of KNS-760704 in healthy volunteers
    Graham, Cheryl F.
    Mather, James L.
    Ingersoll, Evan W.
    Kramer, William G.
    Hebrank, Gregory T.
    Bozik, Michael E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1107 - 1107
  • [23] Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers
    Kunka, RL
    Hussey, EK
    Shaw, S
    Warner, P
    Aubert, B
    Richard, I
    Fowler, PA
    Pakes, GE
    CEPHALALGIA, 1997, 17 (04) : 532 - 540
  • [24] CIPROFLOXACIN PHARMACOKINETICS IN HEALTHY MALE-VOLUNTEERS AFTER MULTIPLE ORAL DOSES
    AOKI, FY
    SITAR, DS
    MCLEOD, J
    CONLY, JM
    HOBAN, D
    LOUIE, TJ
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A133 - A133
  • [25] A PHASE I ADAPTIVE DESIGN STUDY TO ASSESS SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF GIC-1001 IN HEALTHY VOLUNTEERS.
    Sayegh, L.
    Rufiange, M.
    Sadoune, A. Ait
    Sicard, E.
    Massicotte, J.
    Lefebvre, M.
    Colin, P.
    Ranger, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S63 - S64
  • [26] Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers
    Liang, Beibei
    Wang, Jin
    Bai, Nan
    Chi, Yulong
    Wang, Rui
    Cai, Yun
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (10): : 1184 - 1190
  • [27] A phase I double-blind, placebo-controlled, single rising dose study to determine the safety, tolerability, and pharmacokinetics of oral YM934 in healthy male volunteers
    Burggraaf, J
    Schoemaker, RC
    Terpstra, IJ
    Cohen, AF
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (01): : 45 - 53
  • [28] Safety, Tolerability, and Pharmacokinetics of Single Escalating Doses of Oral Semaglutide in Healthy Male Subjects
    Baekdal, Tine A.
    Blicher, Thalia M.
    Donsmark, Morten
    Sondergaard, Flemming L.
    DIABETES, 2017, 66 : A318 - A318
  • [29] Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers
    Lee, Y
    Conroy, JA
    Stepanavage, ME
    Mendel, CM
    Somers, G
    McLoughlin, DA
    Olah, TV
    De Smet, M
    Keymeulen, B
    Rogers, JD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (04) : 373 - 378
  • [30] Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of Tofacitinib, a Janus Kinase Inhibitor, in Healthy Volunteers
    Krishnaswami, Sriram
    Boy, Mary
    Chow, Vincent
    Chan, Gary
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (02): : 83 - 88
12345